{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:53:43Z","timestamp":1792065223725,"version":"4.4.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,15]]},"DOI":"10.7759\/cureus.117960","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:10:25Z","timestamp":1792062625000},"source":"Crossref","is-referenced-by-count":0,"title":["Recorded Adverse Events and Patient-Reported Outcomes After Intra-articular Extracellular-Vesicle Product Administration for Knee Osteoarthritis: A Retrospective Single-Practice Case Series"],"prefix":"10.7759","author":[{"given":"Jonathan","family":"Courtney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Hollman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-21-01233","article-title":"AAOS clinical practice guideline summary: management of osteoarthritis of the knee (nonarthroplasty), third edition","volume":"30","author":"Brophy RH","year":"2022","unstructured":"Brophy RH, Fillingham YA. AAOS clinical practice guideline summary: management of osteoarthritis of the knee (nonarthroplasty), third edition. J Am Acad Orthop Surg. 2022, 30:e721-9. 10.5435\/JAAOS-D-21-01233","journal-title":"J Am Acad Orthop Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/23259671211030272","article-title":"A systematic review of current clinical practice guidelines on intra-articular hyaluronic acid, corticosteroid, and platelet-rich plasma injection for knee osteoarthritis: an international perspective","volume":"9","author":"Phillips M","year":"2021","unstructured":"Phillips M, Bhandari M, Grant J, Bedi A, Trojian T, Johnson A, Schemitsch E. A systematic review of current clinical practice guidelines on intra-articular hyaluronic acid, corticosteroid, and platelet-rich plasma injection for knee osteoarthritis: an international perspective. Orthop J Sports Med. 2021, 9:10.1177\/23259671211030272","journal-title":"Orthop J Sports Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh JA","year":"2024","unstructured":"Welsh JA, Goberdhan DC, O'Driscoll L, et al.. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024, 13:e12404. 10.1002\/jev2.12404","journal-title":"J Extracell Vesicles"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15376-8","article-title":"Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis","volume":"7","author":"Cosenza S","year":"2017","unstructured":"Cosenza S, Ruiz M, Toupet K, Jorgensen C, No\u00ebl D. Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep. 2017, 7:16214. 10.1038\/s41598-017-15376-8","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000489739","article-title":"Microvesicles from human adipose tissue-derived mesenchymal stem cells as a new protective strategy in osteoarthritic chondrocytes","volume":"47","author":"Tofi\u00f1o-Vian M","year":"2018","unstructured":"Tofi\u00f1o-Vian M, Guill\u00e9n MI, P\u00e9rez Del Caz MD, Silvestre A, Alcaraz MJ. Microvesicles from human adipose tissue-derived mesenchymal stem cells as a new protective strategy in osteoarthritic chondrocytes. Cell Physiol Biochem. 2018, 47:11-25. 10.1159\/000489739","journal-title":"Cell Physiol Biochem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1445-0","article-title":"Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?","volume":"10","author":"Mianehsaz E","year":"2019","unstructured":"Mianehsaz E, Mirzaei HR, Mahjoubin-Tehran M, et al.. Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?. Stem Cell Res Ther. 2019, 10:340. 10.1186\/s13287-019-1445-0","journal-title":"Stem Cell Res Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-024-07979-w","article-title":"Safety and efficacy of placental mesenchymal stromal cells-derived extracellular vesicles in knee osteoarthritis: a randomized, triple-blind, placebo-controlled clinical trial","volume":"25","author":"Bolandnazar NS","year":"2024","unstructured":"Bolandnazar NS, Raeissadat SA, Haghighatkhah H, et al.. Safety and efficacy of placental mesenchymal stromal cells-derived extracellular vesicles in knee osteoarthritis: a randomized, triple-blind, placebo-controlled clinical trial. BMC Musculoskelet Disord. 2024, 25:856. 10.1186\/s12891-024-07979-w","journal-title":"BMC Musculoskelet Disord"},{"key":"ref8","unstructured":"US Food and Drug Administration. Consumer alert on regenerative medicine products including stem cells and exosomes. (2024). Accessed: September 28, 2026: https:\/\/www.fda.gov\/vaccines-blood-biologics\/consumers-biologics\/consumer-alert-regenerative-medicine-products-includ...."},{"key":"ref9","unstructured":"ZEO ScientifiX. Advanced product solutions: patient pure X autologous EV concentrate and DayZero exosomes. Accessed: September 28, 2026: https:\/\/www.zeoscientifix.com\/products."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-016-4719-1","article-title":"Validation of the KOOS, JR: a short-form knee arthroplasty outcomes survey","volume":"474","author":"Lyman S","year":"2016","unstructured":"Lyman S, Lee YY, Franklin PD, Li W, Cross MB, Padgett DE. Validation of the KOOS, JR: a short-form knee arthroplasty outcomes survey. Clin Orthop Relat Res. 2016, 474:1461-71. 10.1007\/s11999-016-4719-1","journal-title":"Clin Orthop Relat Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-015-3705-6","article-title":"Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"G\u00f6rmeli G","year":"2017","unstructured":"G\u00f6rmeli G, G\u00f6rmeli CA, Ataoglu B, \u00c7olak C, Aslant\u00fcrk O, Ertem K. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2017, 25:958-65. 10.1007\/s00167-015-3705-6","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.46582\/jsrm.1202011","article-title":"Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee","volume":"12","author":"Lana JF","year":"2016","unstructured":"Lana JF, Weglein A, Sampson SE, et al.. Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee. J Stem Cells Regen Med. 2016, 12:69-78. 10.46582\/jsrm.1202011","journal-title":"J Stem Cells Regen Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03262-w","article-title":"Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis","volume":"21","author":"Zhao J","year":"2020","unstructured":"Zhao J, Huang H, Liang G, Zeng LF, Yang W, Liu J. Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2020, 21:224. 10.1186\/s12891-020-03262-w","journal-title":"BMC Musculoskelet Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.104403","article-title":"One-year functional outcomes of medial congruent, manually instrumented total knee replacements","volume":"18","author":"Courtney J","year":"2026","unstructured":"Courtney J. One-year functional outcomes of medial congruent, manually instrumented total knee replacements. Cureus. 2026, 18:e104403. 10.7759\/cureus.104403","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/534866-recorded-adverse-events-and-patient-reported-outcomes-after-intra-articular-extracellular-vesicle-product-administration-for-knee-osteoarthritis-a-retrospective-single-practice-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:10:28Z","timestamp":1792062628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/534866-recorded-adverse-events-and-patient-reported-outcomes-after-intra-articular-extracellular-vesicle-product-administration-for-knee-osteoarthritis-a-retrospective-single-practice-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.117960","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}